{
    "eid": "2-s2.0-84952877007",
    "title": "Nephrotoxicity caused by oral antiviral agents in patients with chronic hepatitis B treated in a hospital for tropical diseases in Thailand",
    "cover-date": "2015-12-14",
    "subject-areas": [
        {
            "$": "Pharmacology (medical)",
            "@code": "2736"
        },
        {
            "$": "Pharmacology",
            "@code": "3004"
        }
    ],
    "keywords": [
        "Antiviral agents",
        "Chronic hepatitis B",
        "Nephrotoxicity",
        "Nucleoside",
        "Nucleotide",
        "Thailand"
    ],
    "authors": [
        "Aung Myint Thu"
    ],
    "citedby-count": 4,
    "ref-count": 26,
    "ref-list": [
        "Hepatitis B Virus Infection - Natural History and Clinical Consequences",
        "A systematic review of side effects of nucleoside and nucleotide drugs used for treatment of chronic hepatitis B",
        "Chronic hepatitis B: Update 2009",
        "New developments in the treatment of chronic hepatitis B",
        "Impact of prior lamivudine use on the antiviral efficacy and development of resistance to entecavir in chronic hepatitis B patients",
        "The saga of entecavir",
        "Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B",
        "Safety, efficacy, and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to <18 years) with chronic hepatitis B",
        "Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: Two double-blind, randomized, placebo-controlled studies",
        "Clinical trial: Effects of adefovir dipivoxil therapy in Asian and Caucasian patients with chronic hepatitis B",
        "Resolution of adefovir-related nephrotoxicity by adefovir dose-reduction in patients with chronic hepatitis B",
        "Low Resistance to Adefovir Combined With Lamivudine: A 3-Year Study of 145 Lamivudine-Resistant Hepatitis B Patients",
        "Add-on combination therapy with adefovir dipivoxil induces renal impairment in patients with lamivudine-refractory hepatitis B virus",
        "Hepatology",
        "Efficacy of tenofovir in patients with lamivudine failure is not different from that in nucleoside/nucleotide analogue-na\u00efve patients with chronic hepatitis B",
        "Seven-Year Efficacy and Safety of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection",
        "Tenofovir nephrotoxicity: 2011 update",
        "Renal toxicity associated with tenofovir use",
        "Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B",
        "Fanconi's syndrome associated with prolonged adefovir dipivoxil therapy in a hepatitis B virus patient",
        "Different definitions of prevalent hypertension impact: The clinical epidemiology of hypertension and attainment of healthy people goals",
        "Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B",
        "Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B",
        "Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil",
        "Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir",
        "A consensus statement on the renal monitoring of Australian patients receiving tenofovir based antiviral therapy for HIV/HBV infection"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nakhon Pathom",
            "affilname": "Mahidol University",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}